Portal Hypertension

Portal Hypertension

Overview

↑pressure in portal system from obstruction anywhere along course. Portal veins have NO VALVES → obstruction raises pressure in ALL proximal veins. Default assumption = CIRRHOSIS unless proven otherwise. Normal 10-15mm saline; portal HTN = >30mm saline. Pressure measures: intrasplenic(splenic vein), percutaneous transhepatic(main portal vein), wedged hepatic venous(sinusoidal) — localise obstruction site.

Classification (by site)

1. INTRAHEPATIC — CIRRHOSIS commonest by far. Others: metastatic tumours, nodular regenerative conditions, Budd-Chiari, veno-occlusive disease, schistosomiasis, granulomatous disease, extensive fatty change. Mechanism: fibrosis+thrombosis+nodule pressure. 30-60% of cirrhotics get significant portal HTN.

2. POSTHEPATIC — uncommon. Hepatic vein→IVC obstruction: neoplastic occlusion/thrombosis (incl. Budd-Chiari), OR prolonged CHF/constrictive pericarditis (transmitted pressure).

3. PREHEPATIC — blockage before sinusoids: portal vein thrombosis/neoplastic obstruction, myelofibrosis, congenital absence.

(Rare idiopathic type = non-cirrhotic portal fibrosis — separate entity, see Cirrhosis of the Liver)

Major sequelae (4)

1. ASCITES — peritoneal fluid excess, accompanies cirrhosis/diffuse liver disease. Transudate (SG 1.010, protein<3g/dl). Neutrophils=infection; RBCs=intra-abdominal cancer. SPONTANEOUS BACTERIAL PERITONITIS = serious complication (no identifiable source).

Pathogenesis (clinically detectable >500ml): SYSTEMIC: ↓plasma oncotic pressure (hypoalbuminaemia: ↓synthesis+peritoneal loss); HYPERALDOSTERONISM (↓renal blood flow+↓hepatic clearance); impaired renal excretion (↓renal flow+↑ADH→Na/water retention) LOCAL: ↑portal pressure (not alone causative, combines with above to LOCALISE fluid); ↑hepatic lymph formation (Budd-Chiari/↑sinusoidal pressure→oozes from surface)

2. VARICES (porto-systemic shunts) — form where portal+systemic circulations share capillary beds:

• OESOPHAGEAL varices — MASSIVE HAEMATEMESIS, MOST IMPORTANT consequence overall (leading death cause)
• Haemorrhoids — LESS serious bleeding than varices
• CAPUT MEDUSAE — paraumbilical plexus, dilated veins radiating from umbilicus
• Retroperitoneal anastomoses — veins of Retzius/Sappey

3. SPLENOMEGALY — congestive, 500-1000g, palpable. LARGER in younger patients + MACRONODULAR cirrhosis (vs micronodular).

4. HEPATIC ENCEPHALOPATHY — porto-systemic shunting→brain syndrome (disturbed consciousness, flapping tremor). Associated with advanced disease. (Full mechanism: see Hepatic Failure)

Clinical relevance

Ascites’ 3 systemic + 2 local factors = why management needs MORE than diuretics alone (diuretics fix renal/aldosterone axis, NOT the oncotic-pressure deficit from hypoalbuminaemia). Oesophageal varices = single MOST dangerous sequela — disproportionately deadly vs how “minor” collateral formation sounds. Intrahepatic/posthepatic/prehepatic classification = directly determines management (cirrhosis-driven ≠ surgically correctable like isolated prehepatic thrombosis) — clinically consequential, not just academic. Spleen size correlating with cirrhosis subtype (bigger in macronodular) = subtle morphology-clinical link.

---

Portal Hypertension

Overview

↑pressure in portal system from obstruction anywhere along course. Portal veins have NO VALVES → obstruction raises pressure in ALL proximal veins. Default assumption = CIRRHOSIS unless proven otherwise. Normal 10-15mm saline; portal HTN = >30mm saline. Pressure measures: intrasplenic(splenic vein), percutaneous transhepatic(main portal vein), wedged hepatic venous(sinusoidal) — localise obstruction site.

Classification (by site)

1. INTRAHEPATIC — CIRRHOSIS commonest by far. Others: metastatic tumours, nodular regenerative conditions, Budd-Chiari, veno-occlusive disease, schistosomiasis, granulomatous disease, extensive fatty change. Mechanism: fibrosis+thrombosis+nodule pressure. 30-60% of cirrhotics get significant portal HTN.

2. POSTHEPATIC — uncommon. Hepatic vein→IVC obstruction: neoplastic occlusion/thrombosis (incl. Budd-Chiari), OR prolonged CHF/constrictive pericarditis (transmitted pressure).

3. PREHEPATIC — blockage before sinusoids: portal vein thrombosis/neoplastic obstruction, myelofibrosis, congenital absence.

(Rare idiopathic type = non-cirrhotic portal fibrosis — separate entity, see Cirrhosis of the Liver)

Major sequelae (4)

1. ASCITES — peritoneal fluid excess, accompanies cirrhosis/diffuse liver disease. Transudate (SG 1.010, protein<3g/dl). Neutrophils=infection; RBCs=intra-abdominal cancer. SPONTANEOUS BACTERIAL PERITONITIS = serious complication (no identifiable source).

Pathogenesis (clinically detectable >500ml): SYSTEMIC: ↓plasma oncotic pressure (hypoalbuminaemia: ↓synthesis+peritoneal loss); HYPERALDOSTERONISM (↓renal blood flow+↓hepatic clearance); impaired renal excretion (↓renal flow+↑ADH→Na/water retention) LOCAL: ↑portal pressure (not alone causative, combines with above to LOCALISE fluid); ↑hepatic lymph formation (Budd-Chiari/↑sinusoidal pressure→oozes from surface)

2. VARICES (porto-systemic shunts) — form where portal+systemic circulations share capillary beds:

• OESOPHAGEAL varices — MASSIVE HAEMATEMESIS, MOST IMPORTANT consequence overall (leading death cause)
• Haemorrhoids — LESS serious bleeding than varices
• CAPUT MEDUSAE — paraumbilical plexus, dilated veins radiating from umbilicus
• Retroperitoneal anastomoses — veins of Retzius/Sappey

3. SPLENOMEGALY — congestive, 500-1000g, palpable. LARGER in younger patients + MACRONODULAR cirrhosis (vs micronodular).

4. HEPATIC ENCEPHALOPATHY — porto-systemic shunting→brain syndrome (disturbed consciousness, flapping tremor). Associated with advanced disease. (Full mechanism: see Hepatic Failure)

Clinical relevance

Ascites’ 3 systemic + 2 local factors = why management needs MORE than diuretics alone (diuretics fix renal/aldosterone axis, NOT the oncotic-pressure deficit from hypoalbuminaemia). Oesophageal varices = single MOST dangerous sequela — disproportionately deadly vs how “minor” collateral formation sounds. Intrahepatic/posthepatic/prehepatic classification = directly determines management (cirrhosis-driven ≠ surgically correctable like isolated prehepatic thrombosis) — clinically consequential, not just academic. Spleen size correlating with cirrhosis subtype (bigger in macronodular) = subtle morphology-clinical link.

Portal Hypertension

Overview

Portal hypertension is a rise in portal system pressure, usually following obstruction to portal blood flow anywhere along its course. Portal veins have no valves, so obstruction anywhere raises pressure in all veins proximal to it. Unless proven otherwise, portal hypertension implies obstruction from cirrhosis of the liver. Normal portal venous pressure is low (10–15 mm saline); portal hypertension occurs above 30 mm saline. Intrasplenic pressure reflects splenic vein pressure; percutaneous transhepatic pressure reflects the main portal vein; wedged hepatic venous pressure reflects sinusoidal pressure — these measurements help localise the obstruction site.

Classification (by Obstruction Site)

1. Intrahepatic — cirrhosis is by far the commonest cause. Other causes: metastatic tumours, non-cirrhotic nodular regenerative conditions, hepatic venous obstruction (Budd-Chiari syndrome), veno-occlusive disease, schistosomiasis, diffuse granulomatous disease, extensive fatty change. Obstruction from fibrosis, thrombosis, and regenerative-nodule pressure. 30–60% of cirrhosis patients develop significant portal hypertension.

2. Posthepatic — uncommon; obstruction to blood flow through the hepatic vein into the IVC. Causes: neoplastic occlusion/thrombosis of the hepatic vein or IVC (including Budd-Chiari syndrome); prolonged congestive heart failure and constrictive pericarditis can also cause it by transmitting elevated pressure through hepatic vessels into the portal vein.

3. Prehepatic — blockage before portal blood reaches hepatic sinusoids. Causes: portal vein thrombosis/neoplastic obstruction before hepatic ramification, myelofibrosis, congenital portal vein absence.

(Rare idiopathic portal hypertension with non-cirrhotic portal fibrosis is a separate entity — see the Cirrhosis of the Liver topic.)

Major Sequelae

Irrespective of the underlying mechanism, four major clinical consequences follow:

1. Ascites

Excessive fluid accumulation in the peritoneal cavity, frequently accompanying cirrhosis and other diffuse liver disease; associated with haemodilution, oedema, decreased urinary output. Ascitic fluid is usually a transudate (specific gravity 1.010, protein <3 g/dl, extracellular-fluid-like electrolytes), with a few mesothelial/mononuclear cells. Neutrophils suggest secondary infection; RBCs suggest disseminated intra-abdominal cancer. Spontaneous bacterial peritonitis — spontaneous ascitic fluid infection without any identifiable intra-abdominal infection source — is a serious complication.

Pathogenesis — clinically detectable above ~500 ml. Systemic and local factors combine:

Systemic factors:

• Decreased plasma colloid oncotic pressure — hypoalbuminaemia from impaired hepatic protein synthesis plus albumin loss into the peritoneal cavity → reduced oncotic pressure → water loss into extravascular space.
• Hyperaldosteronism — increased adrenal aldosterone secretion, probably from reduced renal blood flow plus impaired hepatic aldosterone metabolism/excretion.
• Impaired renal excretion — reduced renal blood flow plus excess ADH release → renal sodium/water retention.

Local factors:

• Increased portal pressure — not directly causative alone, but combines with the above to localise fluid retention in the peritoneal cavity.
• Increased hepatic lymph formation — hepatic vein obstruction (e.g. Budd-Chiari) and increased intrasinusoidal pressure in cirrhosis stimulate hepatic lymph formation that oozes from the liver surface.

2. Varices (Collateral Channels / Porto-Systemic Shunts)

Rising portal pressure and obstruction drive blood to bypass the liver via porto-systemic collateral channels, developing wherever systemic and portal circulations share a common capillary bed:

• Oesophageal varices — oesophagogastric varices, frequently manifesting as massive haematemesis; the most important consequence of portal hypertension.
• Haemorrhoids — collaterals between superior/middle/inferior haemorrhoidal veins; bleeding is usually less serious than variceal haematemesis.
• Caput medusae — anastomoses between portal and systemic veins via the paraumbilical plexus, between liver hilum and umbilicus, producing dilated subcutaneous veins radiating from the umbilicus.
• Retroperitoneal anastomoses — portocaval anastomoses via the veins of Retzius and Sappey.

3. Splenomegaly

Congestive splenomegaly from prolonged portal hypertension; spleen may weigh 500–1000 g, easily palpable. Larger in younger patients and in macronodular cirrhosis compared to micronodular.

4. Hepatic Encephalopathy

Porto-systemic venous shunting can produce a complex metabolic/organic brain syndrome — disturbed consciousness, neurologic signs, flapping tremors — particularly associated with advanced hepatocellular disease such as cirrhosis (see Hepatic Failure topic for the full mechanism).

Clinical Relevance

• The three-factor ascites pathogenesis (hypoalbuminaemia, hyperaldosteronism, impaired renal excretion) plus two local factors together explain why ascites management typically needs more than a single intervention — diuretics address the renal/aldosterone axis but not the oncotic-pressure deficit from hypoalbuminaemia.
• Oesophageal varices are worth flagging as the single most clinically dangerous sequela of the four — massive haematemesis from variceal rupture is a leading cause of death in cirrhosis, disproportionate to how “minor” collateral vessel formation might otherwise sound.
• The intrahepatic/posthepatic/prehepatic classification directly determines management approach — cirrhosis-driven (intrahepatic) portal hypertension is not surgically correctable the way an isolated prehepatic portal vein thrombosis might be, making accurate localisation clinically consequential, not just academic.
• Spleen size correlating with cirrhosis subtype (larger in macronodular) is a subtle but genuine morphology-to-clinical-finding link worth retaining alongside the broader micro-vs-macronodular comparison.

---

Portal Hypertension

Overview

Portal hypertension is a rise in portal system pressure, usually following obstruction to portal blood flow anywhere along its course. Portal veins have no valves, so obstruction anywhere raises pressure in all veins proximal to it. Unless proven otherwise, portal hypertension implies obstruction from cirrhosis of the liver. Normal portal venous pressure is low (10–15 mm saline); portal hypertension occurs above 30 mm saline. Intrasplenic pressure reflects splenic vein pressure; percutaneous transhepatic pressure reflects the main portal vein; wedged hepatic venous pressure reflects sinusoidal pressure — these measurements help localise the obstruction site.

Classification (by Obstruction Site)

1. Intrahepatic — cirrhosis is by far the commonest cause. Other causes: metastatic tumours, non-cirrhotic nodular regenerative conditions, hepatic venous obstruction (Budd-Chiari syndrome), veno-occlusive disease, schistosomiasis, diffuse granulomatous disease, extensive fatty change. Obstruction from fibrosis, thrombosis, and regenerative-nodule pressure. 30–60% of cirrhosis patients develop significant portal hypertension.

2. Posthepatic — uncommon; obstruction to blood flow through the hepatic vein into the IVC. Causes: neoplastic occlusion/thrombosis of the hepatic vein or IVC (including Budd-Chiari syndrome); prolonged congestive heart failure and constrictive pericarditis can also cause it by transmitting elevated pressure through hepatic vessels into the portal vein.

3. Prehepatic — blockage before portal blood reaches hepatic sinusoids. Causes: portal vein thrombosis/neoplastic obstruction before hepatic ramification, myelofibrosis, congenital portal vein absence.

(Rare idiopathic portal hypertension with non-cirrhotic portal fibrosis is a separate entity — see the Cirrhosis of the Liver topic.)

Major Sequelae

Irrespective of the underlying mechanism, four major clinical consequences follow:

1. Ascites

Excessive fluid accumulation in the peritoneal cavity, frequently accompanying cirrhosis and other diffuse liver disease; associated with haemodilution, oedema, decreased urinary output. Ascitic fluid is usually a transudate (specific gravity 1.010, protein <3 g/dl, extracellular-fluid-like electrolytes), with a few mesothelial/mononuclear cells. Neutrophils suggest secondary infection; RBCs suggest disseminated intra-abdominal cancer. Spontaneous bacterial peritonitis — spontaneous ascitic fluid infection without any identifiable intra-abdominal infection source — is a serious complication.

Pathogenesis — clinically detectable above ~500 ml. Systemic and local factors combine:

Systemic factors:

• Decreased plasma colloid oncotic pressure — hypoalbuminaemia from impaired hepatic protein synthesis plus albumin loss into the peritoneal cavity → reduced oncotic pressure → water loss into extravascular space.
• Hyperaldosteronism — increased adrenal aldosterone secretion, probably from reduced renal blood flow plus impaired hepatic aldosterone metabolism/excretion.
• Impaired renal excretion — reduced renal blood flow plus excess ADH release → renal sodium/water retention.

Local factors:

• Increased portal pressure — not directly causative alone, but combines with the above to localise fluid retention in the peritoneal cavity.
• Increased hepatic lymph formation — hepatic vein obstruction (e.g. Budd-Chiari) and increased intrasinusoidal pressure in cirrhosis stimulate hepatic lymph formation that oozes from the liver surface.

2. Varices (Collateral Channels / Porto-Systemic Shunts)

Rising portal pressure and obstruction drive blood to bypass the liver via porto-systemic collateral channels, developing wherever systemic and portal circulations share a common capillary bed:

• Oesophageal varices — oesophagogastric varices, frequently manifesting as massive haematemesis; the most important consequence of portal hypertension.
• Haemorrhoids — collaterals between superior/middle/inferior haemorrhoidal veins; bleeding is usually less serious than variceal haematemesis.
• Caput medusae — anastomoses between portal and systemic veins via the paraumbilical plexus, between liver hilum and umbilicus, producing dilated subcutaneous veins radiating from the umbilicus.
• Retroperitoneal anastomoses — portocaval anastomoses via the veins of Retzius and Sappey.

3. Splenomegaly

Congestive splenomegaly from prolonged portal hypertension; spleen may weigh 500–1000 g, easily palpable. Larger in younger patients and in macronodular cirrhosis compared to micronodular.

4. Hepatic Encephalopathy

Porto-systemic venous shunting can produce a complex metabolic/organic brain syndrome — disturbed consciousness, neurologic signs, flapping tremors — particularly associated with advanced hepatocellular disease such as cirrhosis (see Hepatic Failure topic for the full mechanism).

Clinical Relevance

• The three-factor ascites pathogenesis (hypoalbuminaemia, hyperaldosteronism, impaired renal excretion) plus two local factors together explain why ascites management typically needs more than a single intervention — diuretics address the renal/aldosterone axis but not the oncotic-pressure deficit from hypoalbuminaemia.
• Oesophageal varices are worth flagging as the single most clinically dangerous sequela of the four — massive haematemesis from variceal rupture is a leading cause of death in cirrhosis, disproportionate to how “minor” collateral vessel formation might otherwise sound.
• The intrahepatic/posthepatic/prehepatic classification directly determines management approach — cirrhosis-driven (intrahepatic) portal hypertension is not surgically correctable the way an isolated prehepatic portal vein thrombosis might be, making accurate localisation clinically consequential, not just academic.
• Spleen size correlating with cirrhosis subtype (larger in macronodular) is a subtle but genuine morphology-to-clinical-finding link worth retaining alongside the broader micro-vs-macronodular comparison.

Portal Hypertension

• Three-level obstruction site classification (prehepatic/intrahepatic/posthepatic) radiating to their causes
• Central portal hypertension node branching to its four major sequelae (ascites, varices, splenomegaly, encephalopathy), with the four named varix sites marked on a body outline

---

Portal Hypertension

• Three-level obstruction site classification (prehepatic/intrahepatic/posthepatic) radiating to their causes
• Central portal hypertension node branching to its four major sequelae (ascites, varices, splenomegaly, encephalopathy), with the four named varix sites marked on a body outline

Multiple Choice Questions (1)